SEM
Income statement / Annual
Last year (2023), Select Medical Holdings Corporation's total revenue was $6.66 B,
an increase of 5.22% from the previous year.
In 2023, Select Medical Holdings Corporation's net income was $243.49 M.
See Select Medical Holdings Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$6.66 B
|
$6.33 B
|
$6.20 B
|
$5.53 B
|
$5.45 B
|
$5.08 B
|
$4.44 B
|
$4.29 B
|
$3.74 B
|
$3.07 B
|
| Cost of Revenue |
$5.73 B |
$5.60 B |
$5.29 B |
$4.71 B |
$4.64 B |
$4.34 B |
$3.73 B |
$3.66 B |
$3.21 B |
$2.58 B |
| Gross Profit |
$932.04 M |
$733.38 M |
$919.37 M |
$821.34 M |
$812.92 M |
$740.20 M |
$709.43 M |
$621.18 M |
$531.20 M |
$482.68 M |
| Gross Profit Ratio |
0.14 |
0.12 |
0.15 |
0.15 |
0.15 |
0.15 |
0.16 |
0.14 |
0.14 |
0.16 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$170.19 M
|
$153.04 M
|
$146.98 M
|
$138.04 M
|
$128.46 M
|
$121.27 M
|
$114.05 M
|
$106.93 M
|
$92.05 M
|
$85.25 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$170.19 M
|
$153.04 M
|
$146.98 M
|
$138.04 M
|
$128.46 M
|
$121.27 M
|
$114.05 M
|
$106.93 M
|
$92.05 M
|
$85.25 M
|
| Other Expenses |
$206.97 M |
$177.06 M |
$58.62 M |
$115.65 M |
$212.58 M |
$201.66 M |
-$49,000.00 |
$42.65 M |
$104.98 M |
$68.35 M |
| Operating Expenses |
$759.51 M |
$330.09 M |
$205.59 M |
$253.68 M |
$341.04 M |
$322.92 M |
$274.06 M |
$252.24 M |
$197.03 M |
$153.60 M |
| Cost And Expenses |
$6.11 B |
$5.93 B |
$5.49 B |
$4.96 B |
$4.98 B |
$4.66 B |
$4.01 B |
$3.92 B |
$3.41 B |
$2.74 B |
| Interest Income |
$0.00 |
$169.11 M |
$5.35 M |
$153.01 M |
$200.57 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$198.64 M |
$169.11 M |
$135.99 M |
$153.01 M |
$200.57 M |
$198.49 M |
$154.70 M |
$170.08 M |
$112.82 M |
$85.45 M |
| Depreciation &
Amortization |
$208.74 M
|
$205.83 M
|
$202.65 M
|
$205.66 M
|
$212.58 M
|
$201.66 M
|
$160.01 M
|
$145.31 M
|
$104.98 M
|
$68.35 M
|
| EBITDA |
$763.62 M
|
$585.31 M
|
$772.72 M
|
$683.30 M
|
$684.46 M
|
$621.83 M
|
$517.18 M
|
$448.39 M
|
$384.49 M
|
$352.83 M
|
| EBITDA Ratio |
0.11 |
0.1 |
0.16 |
0.15 |
0.13 |
0.13 |
0.14 |
0.13 |
0.13 |
0.13 |
| Operating Income Ratio
|
0.08
|
0.06
|
0.12
|
0.1
|
0.09
|
0.08
|
0.08
|
0.07
|
0.07
|
0.09
|
| Total Other
Income/Expenses Net |
-$172.52 M
|
-$142.70 M
|
-$84.05 M
|
-$111.18 M
|
-$207.13 M
|
-$181.73 M
|
-$153.42 M
|
-$119.11 M
|
-$66.36 M
|
-$80.68 M
|
| Income Before Tax |
$382.36 M |
$260.58 M |
$629.72 M |
$456.47 M |
$264.75 M |
$235.55 M |
$202.46 M |
$180.73 M |
$208.43 M |
$203.80 M |
| Income Before Tax Ratio
|
0.06
|
0.04
|
0.1
|
0.08
|
0.05
|
0.05
|
0.05
|
0.04
|
0.06
|
0.07
|
| Income Tax Expense |
$82.63 M |
$62.55 M |
$129.77 M |
$111.87 M |
$63.72 M |
$58.61 M |
-$18.18 M |
$55.46 M |
$72.44 M |
$75.62 M |
| Net Income |
$243.49 M |
$158.99 M |
$402.23 M |
$259.00 M |
$201.03 M |
$137.84 M |
$177.18 M |
$115.41 M |
$130.74 M |
$120.63 M |
| Net Income Ratio |
0.04 |
0.03 |
0.06 |
0.05 |
0.04 |
0.03 |
0.04 |
0.03 |
0.03 |
0.04 |
| EPS |
1.91 |
1.23 |
2.99 |
1.93 |
1.54 |
1.06 |
1.33 |
0.88 |
1 |
0.91 |
| EPS Diluted |
1.91 |
1.23 |
2.99 |
1.93 |
1.54 |
1.06 |
0.87 |
0.87 |
0.99 |
0.91 |
| Weighted Average Shares
Out |
$123.11 M
|
$124.63 M
|
$130.25 M
|
$129.78 M
|
$130.25 M
|
$130.17 M
|
$128.96 M
|
$127.81 M
|
$127.48 M
|
$129.03 M
|
| Weighted Average Shares
Out Diluted |
$123.11 M
|
$124.63 M
|
$130.25 M
|
$129.78 M
|
$130.28 M
|
$130.26 M
|
$129.13 M
|
$127.97 M
|
$127.75 M
|
$129.47 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
